Lyndal Kearney

What is he best known for?

The fields of study he is best known for:

• Gene
• DNA
• Mutation

His scientific interests lie mostly in Genetics, Gene, Molecular biology, Chromosomal translocation and Candidate gene. As part of his studies on Genetics, he often connects relevant areas like Young adult. His Molecular biology research incorporates themes from Complementary DNA, NUP98 Gene and Fusion transcript.

His Chromosomal translocation research integrates issues from Immunology, Cytokine Receptor Gene, Cytokine, Cytokine receptor and B cell. His work investigates the relationship between Candidate gene and topics such as Cytogenetics that intersect with problems in Chromosome Arm, DNA, Tandem repeat, Subtelomere and Telomere. In his research, Fluorescence in situ hybridization is intimately related to Genetic architecture, which falls under the overarching field of Genomics.

His most cited work include:

• Genetic variegation of clonal architecture and propagating cells in leukaemia (644 citations)
• Subtle chromosomal rearrangements in children with unexplained mental retardation. (426 citations)
• Deregulated expression of cytokine receptor gene, CRLF2 , is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia (364 citations)

What are the main themes of his work throughout his whole career to date?

Lyndal Kearney focuses on Genetics, Molecular biology, Chromosomal translocation, Gene and Fluorescence in situ hybridization. His Molecular biology research includes elements of Cosmid, Chromosome 21, Tyrosine kinase, Gene mapping and Chromosome 7. His Chromosomal translocation study combines topics in areas such as Cancer research, Aneuploidy, Monosomy, Karyotype and Cytogenetics.

The Cytogenetics study combines topics in areas such as Pathology, DNA and Candidate gene. His research in Gene tackles topics such as Leukemia which are related to areas like T-cell receptor. His study in Fluorescence in situ hybridization is interdisciplinary in nature, drawing from both In situ hybridization, Complex Karyotype, Myeloid leukemia, Childhood Acute Myeloid Leukemia and Genetic heterogeneity.

He most often published in these fields:

• Genetics (59.83%)
• Molecular biology (35.90%)
• Chromosomal translocation (34.19%)

What were the highlights of his more recent work (between 2010-2019)?

• Genetics (59.83%)
• Leukemia (12.82%)
• Fusion gene (10.26%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Genetics, Leukemia, Fusion gene, Cancer stem cell and SNP array. His work in Exome sequencing, Phenotype, Single-cell analysis, Gene and Somatic evolution in cancer are all subfields of Genetics research. His work deals with themes such as CD135, Cytokine Receptor Gene and B cell, which intersect with Leukemia.

His biological study spans a wide range of topics, including Breakpoint, Clone, CDKN2A, breakpoint cluster region and Single-nucleotide polymorphism. His Cancer stem cell research incorporates elements of Genetic analysis, Genetic heterogeneity and Fluorescence in situ hybridization. His studies deal with areas such as Biophysics, Tissue Array Analysis and In situ hybridization as well as Fluorescence in situ hybridization.

Between 2010 and 2019, his most popular works were:

• Genetic variegation of clonal architecture and propagating cells in leukaemia (644 citations)
• Single cell mutational profiling and clonal phylogeny in cancer (98 citations)
• Genetic and functional diversity of propagating cells in glioblastoma (47 citations)

In his most recent research, the most cited papers focused on:

• Gene
• DNA
• Mutation

Lyndal Kearney mostly deals with Genetics, Genomics, Cancer stem cell, Genetic variation and Targeted therapy. His is involved in several facets of Genetics study, as is seen by his studies on Neuroblastoma RAS viral oncogene homolog, Stem cell, Variegation, DNA profiling and Antibody. The study incorporates disciplines such as Gene rearrangement, Nonsynonymous substitution and Exome in addition to Neuroblastoma RAS viral oncogene homolog.

The study incorporates disciplines such as Cancer cell, Fluorescence in situ hybridization, Genetic heterogeneity and Genetic architecture in addition to Variegation. His Antibody study combines topics from a wide range of disciplines, such as Fusion gene, Gene, Leukemia and T-cell receptor. The concepts of his Leukemia study are interwoven with issues in Phenotype, Lineage and Haematopoiesis.